Viewing StudyNCT05554003



Ignite Creation Date: 2024-05-06 @ 6:07 PM
Last Modification Date: 2024-10-26 @ 2:42 PM
Study NCT ID: NCT05554003
Status: RECRUITING
Last Update Posted: 2022-09-26
First Post: 2022-09-21

Brief Title: Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms NENs MeTe Study
Sponsor: European Institute of Oncology
Organization: European Institute of Oncology

Conditions & Keywords Data

Conditions:
Name
Neuroendocrine Tumors
Frailty
Chemotherapy Effect
Keywords:
Name View
Neuroendocrine tumors View
NETs View
NENs View
Unfit View
Chemotherapy View
Metronomic View
Advanced View
Phase II View
Open label View
Temozolomide View